Total Payments
$899.12
2024 Payments
$124.36
Companies
7
Transactions
13
Medicare Patients
3,226
Medicare Billing
$555,230
Payment Breakdown by Category
Food & Beverage$894.02 (99.4%)
Education$5.10 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $894.02 | 12 | 99.4% |
| Education | $5.10 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Theravance Biopharma Inc. | $261.81 | 5 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $249.81 | 2 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $124.99 | 1 | $0 (2021) |
| Shionogi Inc | $124.36 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $109.94 | 2 | $0 (2023) |
| Oxford Immunotec Inc. | $14.95 | 1 | $0 (2017) |
| Lilly USA, LLC | $13.26 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $124.36 | 1 | Shionogi Inc ($124.36) |
| 2023 | $140.00 | 2 | E.R. Squibb & Sons, L.L.C. ($125.00) |
| 2021 | $124.99 | 1 | Janssen Pharmaceuticals, Inc ($124.99) |
| 2019 | $138.07 | 2 | E.R. Squibb & Sons, L.L.C. ($124.81) |
| 2017 | $371.70 | 7 | Theravance Biopharma Inc. ($261.81) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/30/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $124.36 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/04/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/06/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Cardiovascular | ||||||
| 07/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/08/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Diabetes | ||||||
| 01/16/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $124.81 | General |
| Category: Cardiovascular | ||||||
| 12/19/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Infectious Disease | ||||||
| 10/25/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: Infectious Disease | ||||||
| 10/05/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Education | In-kind items and services | $5.10 | General |
| Category: Infectious Disease | ||||||
| 08/23/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $94.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Infectious Disease | ||||||
| 03/08/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Infectious Disease | ||||||
| 01/19/2017 | Oxford Immunotec Inc. | TSPOT TB TEST (Device) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Diagnostic Test | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 793 | 1,121 | $257,650 | $135,000 |
| 2022 | 7 | 835 | 1,100 | $254,370 | $127,722 |
| 2021 | 6 | 867 | 1,145 | $257,050 | $145,754 |
| 2020 | 7 | 731 | 1,184 | $258,650 | $146,753 |
Total Patients
3,226
Total Services
4,550
Medicare Billing
$555,230
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 253 | 309 | $101,650 | $48,896 | 48.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 153 | 338 | $62,240 | $36,717 | 59.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 113 | 136 | $27,200 | $16,557 | 60.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 126 | 136 | $34,000 | $16,264 | 47.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 95 | 147 | $19,910 | $10,621 | 53.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 16 | $6,800 | $3,148 | 46.3% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Office | 2023 | 39 | 39 | $5,850 | $2,798 | 47.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 226 | 266 | $87,700 | $47,259 | 53.9% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 225 | 278 | $55,600 | $24,833 | 44.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 138 | 261 | $49,100 | $24,720 | 50.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 116 | 131 | $32,750 | $16,107 | 49.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 76 | 109 | $14,870 | $7,225 | 48.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 26 | 26 | $10,000 | $5,205 | 52.1% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Office | 2022 | 28 | 29 | $4,350 | $2,373 | 54.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 274 | 315 | $97,600 | $59,148 | 60.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 170 | 292 | $53,220 | $28,158 | 52.9% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2021 | 167 | 213 | $42,600 | $24,562 | 57.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 117 | 122 | $27,070 | $15,728 | 58.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 108 | 172 | $23,660 | $11,624 | 49.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 31 | 31 | $12,900 | $6,534 | 50.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 205 | 242 | $73,900 | $45,741 | 61.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 157 | 439 | $79,020 | $42,531 | 53.8% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2020 | 153 | 219 | $43,800 | $26,184 | 59.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 58 | 65 | $27,700 | $13,650 | 49.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 65 | 70 | $14,280 | $9,123 | 63.9% |
About Iya Dubson
Iya Dubson is a Infectious Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2009. The National Provider Identifier (NPI) number assigned to this provider is 1730327677.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Iya Dubson has received a total of $899.12 in payments from pharmaceutical and medical device companies, with $124.36 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($894.02).
As a Medicare-enrolled provider, Dubson has provided services to 3,226 Medicare beneficiaries, totaling 4,550 services with total Medicare billing of $555,230. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Internal Medicine
- Location Brooklyn, NY
- Active Since 01/30/2009
- Last Updated 07/24/2015
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1730327677
Products in Payments
- VIBATIV (Drug) $261.81
- ELIQUIS (Drug) $249.81
- XARELTO (Drug) $124.99
- Fetroja (Drug) $124.36
- BELSOMRA (Drug) $94.94
- PIFELTRO (Drug) $15.00
- TSPOT TB TEST (Device) $14.95
- TRULICITY (Drug) $13.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Brooklyn
Andre Brutus
Infectious Disease — Payments: $379,075
Infectious Disease $379,075
Dr. Joseph Paul, M.d, M.D
Infectious Disease — Payments: $294,392
Infectious Disease $294,392
Marcus Sandling
Infectious Disease — Payments: $69,398
Infectious Disease $69,398
Dr. Jessica Yager, M.d, M.D
Infectious Disease — Payments: $46,298
Infectious Disease $46,298
Yusuf Afacan, M.d, M.D
Infectious Disease — Payments: $27,239
Infectious Disease $27,239
Dr. Jacquelyn Lahoud, M.d, M.D
Infectious Disease — Payments: $9,095
Infectious Disease $9,095